The current stock price for Madrigal Pharmaceuticals Inc (MDGL) is $344.97. The stock experienced a significant increase during the last trading session, reaching $540.0 after opening at $344.97. It dipped to a low of $248.0 before ultimately closing at $311.14.
The market performance of Madrigal Pharmaceuticals Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $377.46 on 02/26/25, with the lowest value for the same timeframe being $200.63, recorded on 10/23/24.
52-week price history of MDGL Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Madrigal Pharmaceuticals Inc’s current trading price is -8.61% away from its 52-week high, while its distance from the 52-week low is 71.94%. The stock’s price range during this period has fluctuated between $200.63 and $377.46. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.3 million for the day, which was evidently higher than the average daily volume of 0.33 million over the last three months.
Financial Performance and Market Capitalization
Madrigal Pharmaceuticals Inc (MDGL) has experienced a quarterly rise of 7.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.66B and boasts a workforce of 528 employees.
Analysts’ Ratings For Madrigal Pharmaceuticals Inc
As of right now, 10 analysts are rating Madrigal Pharmaceuticals Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 308.88, with a change in price of -6.06. Similarly, Madrigal Pharmaceuticals Inc recorded 354,275 in trading volume during the last 100 days, posting a change of -1.73%.
MDGL Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MDGL stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.17.
MDGL Stock Stochastic Average
The raw stochastic average for Madrigal Pharmaceuticals Inc over the last 50 days is presently at 86.07%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 84.39%. Further, the company’s Stochastic %K and %D values for the last 20 days were 79.48% and 85.56%, respectively.
MDGL Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 20.68% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 13.59%. Over the past 30 days, the price of MDGL has fallen by 16.71%. And in the last five days, it has surged by 11.79%.
